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SUMMARY
Introduction Sleep disorders and psychological disturbances are common in end-stage renal disease 
(ESRD) patients. However, despite their frequency and importance, such conditions often go unnoticed, 
since all patients do not clearly manifest fully expressed symptoms.
Objective This study aimed to determine the prevalence of depression and poor sleep quality and 
to examine the association between these disorders and demographic, clinical and treatment-related 
characteristics of ESRD patients on hemodialysis (HD).
Methods The study included 222 patients (132 men and 90 women), mean age 57.3±11.9 years, from 3 
HD centers in Central Serbia, which provided us with biochemical parameters and demographic data. 
Sleep quality and depression were assessed using the Pittsburgh Sleep Quality Index (PSQI) and Beck 
Depression Inventory (BDI), respectively.
Results The average BDI was 16.1±11.3. Depressed patients were significantly older (p=0.041), had a 
significantly lower dialysis adequacy (p=0.027) and a significantly worse quality of sleep (p<0.001), while 
they did not show significant difference as regarding sex, employment, marital status, comorbidities, 
dialysis type, dialysis vintage, shift and laboratory parameters. The average PSQI was 7.8±4.5 and 64.2% 
of patients were poor sleepers. Poor sleepers were significantly older (p=0.002), they were more often 
females (p=0.027) and had a significantly higher BDI (p<0.001), while other investigated variables were 
not correlated with sleep quality. A statistically significant positive correlation was found between BDI 
and PSQI (r=0.604; p<0.001).
Conclusion Depression and poor sleep quality are frequent and interrelated among HD patients.
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INTRODUCTION
Patients on hemodialysis (HD) are thought to 
be highly susceptible to emotional problems 
because of the chronic stress related to disease 
burden, dietary restrictions, functional limita-
tions, associated chronic illnesses, adverse ef-
fects of medications, changes in self-perception 
and fear of death.
Depression is generally accepted to be the 
commonest psychological problem encoun-
tered in patients with end-stage renal disease 
(ESRD) [1]. Among HD patients it is associated 
with lower quality of life, lower adherence to 
treatment regimens, more co-morbid condi-
tions, more functional impairments and higher 
mortality rate [2, 3]. It possibly affects medical 
outcomes in these patients through modifica-
tion of immunologic and stress responses, im-
pact on nutritional status, and/or reduction of 
compliance with prescribed dialysis and medi-
cal regimens [4]. Although prevalent, depres-
sion is still often unrecognized since there is a 
strong overlap between uremic and depressive 
symptoms.
Sleep is important for overall physical and 
mental well-being. Manifestations of sleep dis-
turbances can include irregularity in sleeping 
habits, difficulty falling asleep, early morning 
awakening and frequent awakening at night, 
sleep apnea, periodic limb movement during 
sleep and restless legs syndrome. The etiology 
of sleep disorders in dialysis patients is not 
completely understood, but it is known to be 
multi-factorial. Duration of dialysis therapy, 
high levels of urea and/or creatinine, pain, 
disability, malnutrition, muscle cramps, pe-
ripheral neuropathy and somatic complaints 
such as pruritus and bone pain, all common 
in ESRD patients, were found to contribute 
to the development of sleep disturbances [5]. 
The prevalence of sleep problems, on the other 
hand, is associated with impaired quality of life 
and higher mortality in patients with ESRD [6].  
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Despite their frequency and importance, depressive and 
sleep disorders often go unnoticed, since not all patients 
clearly manifest the symptoms. Particularly in ESRD pa-
tients’ the symptoms of depression may be similar to those 
that occur with kidney failure or uremia per se, therefore 
the diagnosis and treatment of depression is often delayed 
because the symptoms are disguised by/or attributed to 
uremia. Some studies suggest that depressive disorder and 
poor sleep quality are independent predictors of health-
related quality of life, morbidity and mortality [3, 7, 8]. 
Still, the complex nature of the individual relationships 
involving poor sleep quality and depression with quality 
of life, morbidity and mortality of HD patients is yet to be 
thoroughly investigated.
OBJECTIVE
In this study we sought to determine the prevalence of 
depression and poor sleep quality and to examine the as-
sociation between these disorders and demographic, clini-
cal and treatment-related characteristics of ESRD patients 
on HD.
METHODS
Patients from 3 dialysis centers in Central Serbia (Novi Pa-
zar, Kruševac and Smederevska Palanka), undergoing HD 
for at least 3 months, in stable condition and with grossly 
normal cognition, were invited to participate in this cross-
sectional study. A total of 222 patients gave their informed 
consent and filled in standardized questionnaires (see be-
low). We also recorded patients’ demographic data and 
biochemical parameters within one month of their inter-
view. The study protocol was reviewed and approved by 
the Ethical Committee, School of Medicine, University of 
Belgrade.
The patients were administered two questionnaires: 
Beck Depression Inventory (BDI), second version, for the 
level of depression [9] and Pittsburgh Sleep Quality Index 
(PSQI) to assess the quality of sleep [10].
The BDI is the most widely used tool for self-assess-
ment of the level of depression for the purposes of clinical 
research. This questionnaire consists of 21 questions, each 
of which features 4 response options for the previous 2 
weeks. A higher score for this questionnaire indicates a 
greater level of depression. Patients who had a BDI score 
≥14 were considered to have depressive symptoms [11]. 
The second version of BDI used in this research allows 
reliable testing of patients over 65 years of age. The BDI 
has been used in several studies of patients with ESRD and 
has been shown to correlate highly with diagnostic criteria 
of depression, quality of life, functional status, severity of 
illness and mortality over time [12]. It had been previously 
validated in the population of HD patients in Serbia [11].
PSQI assesses the quality of sleep during the previous 
1-month period and comprised 19 self-rated questions that 
yielded information relating to 7 specific patient compo-
nents, such as subjective sleep quality, sleep latency, sleep 
duration, sleep efficiency, sleep disturbance, use of sleep-
inducing medication, and level of daytime dysfunction. 
Each component was scored according to a scale from 0-3, 
and the overall questionnaire yielded a global PSQI score 
between 0-21, where a higher final score indicated a lower 
quality of sleep.
The original English versions of these two question-
naires were translated to Serbian by a licensed translator 
for the purpose of this investigation.
Venous blood samples for laboratory analyses were 
drawn before and immediately after the first dialysis ses-
sion of the week. Hemoglobin (HGB) was determined with 
the cyanmethemoglobin method (reference range for HD 
patients 110-112 g/dl) [13] on the Cell Dyn 1700 counter. 
Hematocrit (HCT) was calculated from the equation HCT 
= (MCV × erythrocyte count)/10. Serum iron (Fe2+) and 
total iron binding capacity (TIBC) were determined with 
an Opton spectrophotometer. Transferrin saturation in-
dex was calculated from the equation TSAT = (Fe2+/TIBC) 
×100% (TSAT – transferin saturation; TIBC – total iron-
binding capacity) (normal range 20-40%) [13]. Serum fer-
ritin was determined by immunochemistry MEIA tech-
nique, on (reference range 400–600 ng/mL) [13]. Serum 
urea was measured by urease glutamate dehydrogenase 
method. The Alcyon machine (Abbot) was used to meas-
ure serum calcium by photometry (reference range 2.3-2.7 
mmol/L), serum phosphates by photometric UV method 
(normal range 0.8-1.5 mmol/L) and serum albumin by 
spectrophotometry staining with bromcresol green (lower 
threshold for HD patients is 40 g/l). Intact parathyroid 
hormone (iPTH) was determined on autogenous counter, 
by immunoradiometric assay ELSA-PTH (CIS, France), 
the recommended range for HD patients is 150-300 pg/
mL [13]. Eventual laboratory errors were minimized by an 
internal control system. Dialysis dose was assessed based 
on a single pool Kt/V, calculated by using the Daugirdas’s 
formula [14].
All values recorded were presented as mean ± standard 
deviation. The parameters of interest were analyzed using 
unpaired Students t-test, Mann-Whitney test, chi-square 
test, ANOVA, Kruskal-Wallis test. The Pearson correlation 
coefficient was used to examine association between BDI 
and PSQI. All statistical calculations were performed with 
the Statistical Package for Social Sciences (SPSS version 
19.0; SPSS Inc., Chicago, Illinois, USA) for Windows op-
erating system (Microsoft Corp., Redmond, Washington, 
USA). A p value less than 0.05 was considered significant.
RESULTS
Demographic and dialysis-related characteristics of the 
study population are presented in Table 1. Men com-
prised 59.5% of the study population. The mean age was 
57.3±11.9 years. Most patients (72.1%) were married, and 
only 4 (1.8%) were actively employed. HD was performed 
on a thrice weekly basis using machinery with control-
led ultrafiltration, with bicarbonate based dialysate and      
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polysulfone high and low flux dialysers. One third of 
patients (69; 31.1%) were on low-flux biacarbonate di-
alysis, 114 (51.3%) on high-flux bicarbonate dialysis and 
39 (17.6%) were on hemodialfiltration (HDF). The aver-
age dialysis vintage was 61.4±60.3 months (range 3–324 
months). Exactly 50% of patients were dialyzed in the 
morning shift. Twenty-eight patients (12.6%) had diabe-
tes, 13 (5.9%) were hepatitis C positive and 9 (4.1%) were 
hepatitis B positive.
Depression
Signs of depression were found in 109 (49.1%) patients. 
Among them 41 (18.4% of all the patients) had mild de-
pression (BDI=14–19), 33 (14.9%) had moderate depres-
sion (BDI=20–28) and 35 (15.8%) had severe depression 
(BDI≥29). The average BDI was 16.1±11.3 (range 0–52). 
Depressed patients were significantly older (p=0.041), 
while sex, employment, marital status and comorbidities 
(diabetes and hepatitis) were not significantly correlated 
with depression (Table 2). Dialysis type, dialysis vintage 
and shift were not significantly related to the presence of 
depression, but depressed patients had significantly lower 
dialysis adequacy (p=0.027). The depressed patients had 
significantly worse quality of sleep than patients without 
signs of depression (p<0.001).
Serum hemoglobin, calcium, phosphorus, iPTH and 
albumin were almost identical in depressed and non-de-
pressed patients. Serum ferritin was higher in depressed 
patients, while TSAT was higher in non-depressed ones. 
Results of blood analyses did not significantly correlate 
with presence of depression (Table 3).
Quality of Sleep
The PSQI ranged from 0-19 (average 7.8±4.5), and 142 
patients (64.2%) were poor sleepers. The average sleep 
latency, representing the length of time that it takes to 
accomplish the transition from full wakefulness to sleep 
was 36.86 ± 35.90 minutes (recommended <20 minutes). 
The average sleep efficiency, representing the ratio of time 
spent asleep (total sleep time) to the amount of time spent 
in bed, was 81.73±18.00% (reference range 80-95%). The 
patients slept 6.87±1.86 hours/night on average (recom-
mended sleep time ≥7 hours). Poor sleepers were signifi-
cantly older (p=0.002) and they were more often females 
(p=0.027). Compared with good sleepers, poor sleepers 
had a significantly higher BDI (p<0.001). Marital status, 
employment, comorbidities (diabetes and hepatitis), type 
of dialysis, dialysis vintage, shift and adequacy were not 
significantly correlated with sleep quality (Table 4).
Poor sleepers had higher hemoglobin, calcium and 
iPTH than good sleepers, and lower ferritin and TSAT, but 
the differences were not statistically significant (Table 5).
A statistically significant positive correlation was found 
between BDI and PSQI (r=0.604; p<0.00; Graph 1).
Table 1. Demographic and dialysis-related characteristics of the study 
population at the beginning of the investigation
Variables Values
Age (years) 57.3±11.9
Male/Female 132/90
Married/Not married 160/62
Employed/Unemployed 4/218
Hemoglobin (g/l) 102.6±16.9
Calcium (mmol/l) 2.3±0.2
Phosphorus (mmol/l) 1.6±0.4
iPTH (pg/ml) 225.7±334.6
Ferritin (ng/ml) 309.2±31.8
Albumin (g/l) 35.3±4.9
Kt/V 1.2±0.3
Values are expressed as mean value ± standard deviation, and number of 
patients.
Table 2. Comparison of demographic data, comorbidity, dialysis-
related characteristics and quality of sleep in patients with and 
without depression
Variables
Patients 
with 
depression
(BDI≥14)
Patients 
without 
depression
(BDI<14)
p
Age (years) 59.0±11.0 55.7±12.6 0.041
Sex
Male 63 (57.8%) 69 (61.1%)
0.620
Female 46 (42.2%) 44 (38.9%)
Marrital 
status
Married 82 (75.2%) 78 (69.0%)
0.607
Unmarried 13 (11.9%) 18 (15.9%)
Divorced 3 (2.8%) 6 (5.3%)
Widowed 11 (10.1%) 11 (9.7%)
Employment
Employed 107 (98.2%) 111 (98.2%)
1.000
Unemployed 2 (1.8%) 2 (1.8%)
Diabetes
Yes 16 (14.7%) 12 (10.6%)
0.362
No 93 (85.3%) 101 (89.4%)
Hepatitis C
Yes 8 (7.3%) 5 (4.4%)
0.355
No 101 (92.7%) 108 (95.6%)
Hepatitis B
Yes 4 (3.7%) 5 (4.4%)
1.000
No 105 (96.3%) 108 (95.6%)
Type of 
dialysis
Low flux 44 (40.4%) 40 (35.4%)
0.670 High flux 52 (47.7%) 56 (49.6%)
Hemodiaflitration 13 (11.9%) 17 (15.0%)
Dialysis vintage (months) 61.3±55.8 61.5±55.8 0.395
Shift
Morning 52 (47.7%) 60 (53.1%)
0.422
Afternoon 57 (52.3%) 53 (46.9%)
Adequacy (Kt/V) 1.1±0.2 1.2±0.4 0.027
PSQI 10.1±4.6 5.7±3.3 <0.001
BDI – Beck Depression Inventory; PSQI – Pittsburgh Sleep Quality Index
Values are expressed as mean value ± standard deviation, and number of 
patients (%).
Table 3. Comparison of laboratory data between the patients with 
and without depression (mean value ± SD)
Laboratory data
Patients with 
depression
(BDI≥14)
Patients without 
depression
(BDI<14)
p
Hemoglobin (g/l) 102.4±17.8 102.8±16.1 0.884
Calcium (mmol/l) 2.3±0.2 2.3±0.2 0.619
Phosphorus (mmol/l) 1.60±0.4 1.63±0.4 0.617
iPTH (pg/ml) 211.6±320.6 241.5±350.8 0.556
Ferritin (ng/ml) 283.8±249.5 334.6±373.4 0.241
TSAT (%) 28.2±28.8 25.8±14.6 0.430
Albumins (g/l) 34.7±5.0 34.8±4.8 0.080  
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DISCUSSION
Dialysis patients face the burdens of long-term illness, nu-
merous treatment or disease-related stressors, the chal-
lenge of life-long behavior change, emotional distress and 
loss of personal control [2]. Depression is considered the 
most frequent psychological issue among HD patients. 
Its prevalence varies widely across studies, which may, in 
part, be a reflection of different diagnostic tools used [15]. 
Most recent studies, however, used the BDI to assess the 
prevalence of depressive symptoms in HD population [3, 
11, 16, 17, 18]. In this study we used the second version 
of BDI, which allows reliable testing of patients over 65 
years. The cut-off value of 14 points defining the pres-
ence of depression was adopted based on previous stud-
ies which used the same version of BDI [11, 17, 19]. The 
prevalence of depression of 49.1% found in our study was 
within the 26% to 72.38% range of prevalence reported by 
other authors, even though most previous studies included 
patients under 65 years and a rather smaller number of 
patients, usually less than 100 [3, 11, 16-20]. Similarly, the 
prevalence of moderate to severe depression in our study 
is comparable with the 13.3% to 48.9% prevalence range in 
HD patients in previous studies [11, 16, 21]. The average 
BDI of 16.1 in our HD population is also within the range 
detected in previous studies [3, 16, 17, 19].
In general population depression is usually associated 
with older age, as was noted in our study population [3]. 
However, other studies on HD patients failed to depict 
such correlation, possibly because they included mostly 
younger population, as previously mentioned [2, 3, 11, 
16-20]. Similar to our results, previous studies did not 
report significant correlation between dialysis adequacy 
and depression [3, 22]. On the other hand, dialysis type 
and vintage were not significantly associated with de-
pression in our study population, while other investiga-
tions reported conflicting results on this subject [2, 16, 
17]. Lower BDI and lower prevalence of depression were 
associated with HDF treatment in previous studies [23]. 
Lack of significant difference in our study group might be 
due to the fact that a rather small number of patients were 
receiving HDF, as determined by the National Health Fund 
standards. Some prospective studies suggested that higher 
prevalence of depression is present in HD patients follow-
ing the start of dialysis, but the cross-sectional design of 
our study and the inclusion criterion of at least 3 months 
dialysis vintage preclude such conclusion in our study [24]. 
It is possible that patients eventually accept and adapt to 
the treatment regime, thus lowering the prominence of 
depressive symptoms.
In some previous studies depression in HD patients was 
associated with low levels of hemoglobin and albumin [25, 
26]. Lack of correlation between laboratory parameters of 
anemia and depression in our study may be due to better 
therapeutic correction of anemia in our study group. 
Sleep complaints and their etiology in HD patients have 
received increasing attention over the last years. Several 
studies suggest a potential link between sleep deprivation, 
poor sleep quality and sleep disorders, and increased mor-
Table 4. Comparison of demographic data, comorbidity, dialysis-
related characteristics and depression status in good and poor 
sleepers
Variables
Good 
sleepers 
(PSQI≤5)
Poor 
sleepers 
(PSQI>5)
p
Age (years) 53.7±13.8 59.3±10.1 0.002
Sex
Male 54 (69.2%) 76 (53.9%)
0.027
Female 24 (30.8%) 65 (46.1%)
Marrital 
status
Married 50 (64.1%) 109 (77.3%)
0.071
Unmarried 17 (21.8%) 13 (9.2%)
Divorced 3 (3.8%) 5 (3.5%)
Widowed 8 (10.3%) 14 (9.9%)
Employment
Employed 75 (96.2%) 140 (99.3%)
0.130
Unemployed 3 (3.8%) 1 (0.7%)
Diabetes
Yes 7 (9.0%) 21 (14.9%)
0.209
No 71 (91.0%) 120 (85.1%)
Hepatitis C
Yes 5 (6.4%) 8 (5.7%)
1.000
No 73 (93.6%) 133 (94.3%)
Hepatitis B
Yes 4 (5.1%) 4 (2.8%)
0.460
No 74 (94.9%) 137 (97.2%)
Type of 
dialysis
Low flux 27 (34.6%) 55 (39.0%)
0.386 High flux 37 (47.7%) 70 (49.6%)
Hemodiaflitration 14 (17.9%) 16 (11.3%)
Dialysis vintage (months) 69.8±69.9 56.8±54.5 0.408
Shift
Morning 52 (47.7%) 60 (53.1%)
0.422
Afternoon 57 (52.3%) 53 (46.9%)
Adequacy (Kt/V) 1.2±0.2 1.2±0.4 0.114
BDI 10.3±8.0 19.2±11.6 <0.001
Values are expressed as mean value ± standard deviation, and number of 
patients (%).
Table 5. Comparison of laboratory data in good and poor sleepers 
(mean value ± SD)
Laboratory data Good sleepers 
(PSQI≤5)
Poor sleepers 
(PSQI>5) p
Hemoglobin (g/l) 102.2±17.5 103.1±16.7 0.725
Calcium (mmol/l) 2.2±0.2 2.3±0.2 0.117
Phosphorus (mmol/l) 1.6±0.4 1.6±0.4 0.589
iPTH (pg/ml) 168.8±173.6 257.6±392.7 0.887
Ferritin (ng/ml) 322.4±335.2 302.1±312.4 0.661
TSAT (%) 29.4±25.8 25.6±21.0 0.250
Albumins (g/l) 35.5±4.8 35.2±5.0 0.760
Graph 1. Correlation between Beck Depression Inventory and Pitts-
burgh Sleep Quality Index (r=0.604; p<0.001)
Trbojević-Stanković Ј. et al. Depression and Quality of Sleep in Maintenance Hemodialysis Patients     
441 Srp Arh Celok Lek. 2014 Jul-Aug;142(7-8):437-443
www.srp-arh.rs
tality [6]. Consistent with the results of several previous 
studies, our survey confirmed high prevalence of sleep 
disorders among maintenance HD patients [6, 16, 27, 
28]. A wide variety of potential factors probably contrib-
ute to high prevalence of sleep problems in HD patients, 
including biological, lifestyle and/or psychological factors. 
There is a discrepancy among studies examining sleep in 
the elderly indicating a controversy as to the nature of 
sleep problems associated with aging even in the healthy 
population. Considerable evidence demonstrates that age 
is associated with significant changes in numerous objec-
tive sleep parameters, as well as subjective sleep quality 
determined by the PSQI [29, 30]. Furthermore, some au-
thors found that women reported more insomnia across 
all age groups [31]. Finally, there are conflicting results in 
the literature regarding the role of gender and age in sleep 
diseases in ESRD patients. Significant correlation between 
older age and female gender with poorer sleep quality in 
our study population is consistent with data published by 
several other authors [27, 32].
Some previous studies reported worse sleep quality to 
be associated with longer time on dialysis, morning shift 
and lower Kt/V, but we did not find significant correla-
tions between the type of dialysis, dialysis vintage, dialysis 
adequacy and shift, and sleep quality in our study popula-
tion [27, 28]. Time on dialysis may be associated with pro-
gressive appearance of symptoms and concurrent diseases 
commonly associated with chronic HD treatment, thus 
indirectly influencing the quality of sleep. However, in our 
study population such correlation was not observed. Lack 
of association between dialyzing in the morning shift and 
sleep problems in our study population may be due to the 
fact that we strive to and in most cases achieve to fulfill 
our patients wishes on the shift in which they dialyze, thus 
adjusting dialysis shift with their individual biorhythm.
Sabbatini et al. [28] demonstrated a relationship be-
tween high iPTH and sleep disorders, which might be 
related to pruritus and bone pain. Furthermore, previous 
studies found that poor sleepers had lower hemoglobin 
[33]. We did not find such correlations between sleep 
quality and hemoglobin, PTH, calcium, phosphorus and 
iron stores levels, identically to other authors’ findings 
[16]. This is probably due to the fact that the patients in 
our study population had iPTH levels within the recom-
mended range and almost identical hemoglobin levels in 
good and poor sleepers groups.
Consistent to findings of other authors, poor sleep qual-
ity and depression were found to be significantly corre-
lated in our study population [16, 33, 34].
There are clearly some limitations to our survey. Al-
though we took into consideration several psychosocial 
dimensions, including marital status and employment, we 
omitted some psychosocial factors, such as participants’ 
economic status, level of education, levels of religious and 
spiritual activity, family support and some other emotional 
stresses such as the level of anxiety, worry and fear. Fur-
thermore, although the PSQI contains some questions with 
respect to restless legs syndrome and sleep apnea, those 
factors are not scored and are not informative enough for 
a definitive diagnosis. We did not perform other objective 
sleep measurements such as polysomnography to prove 
our observations, but the correlations between the PSQI 
and polysomnography have been reported to be significant 
in certain domains [35]. The severity and co-morbidity in 
HD patients may be an independent risk factor for depres-
sion and sleep disorders. In this study we only assessed the 
relationship between viral hepatitis and diabetes with de-
pression and sleep quality. A more thorough investigation 
of correlation between dialysis related symptom burden, 
depression and quality of sleep in our study population is 
currently being conducted.
CONCLUSION
Maintenance HD is associated with a high prevalence of 
depression and sleep disturbance. Understanding the de-
gree to which depression and sleep disturbance affects this 
large and growing population may help facilitate the im-
plementation of symptom-alleviating therapies to improve 
psychological and overall well-being, quality of life, and 
consequently, reduce morbidity and mortality risk in this 
population, and their treatment costs. Our results, thus, 
advocate for incorporating a routine assessment and, if 
necessary, treatment of depression and sleep disorders into 
the standard care provided to HD patients.
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КРАТАК САДРЖАЈ
Увод По  ре  ме  ћа  ји спа  ва  ња и пси  хич  ког ста  ту  са се че  сто 
ја  вља  ју код бо  ле  сни  ка с тер  ми  нал  ном ин  су  фи  ци  јен  ци  јом 
бу  бре  га. Упр  кос уче  ста  ло  сти и зна  ча  ју, ова ста  ња се рет  ко 
бла  го  вре  ме  но ди  јаг  но  сти  ку  ју и ле  че, јер се симп  то  ми не ис-
по  ља  ва  ју увек у пу  ном оби  му.
Циљ ра  да Циљ ис  тра  жи  ва  ња био је да се код бо  ле  сни  ка 
на хе  мо  ди  ја  ли  зи про  це  ни пре  ва  лен  ци  ја де  пре  си  је и ло  шег 
ква  ли  те  та спа  ва  ња, као и по  ве  за  ност из  ме  ђу ових по  ре  ме-
ћа  ја и де  мо  граф  ских, кли  нич  ких и од  ли  ка у ве  зи с на  чи  ном 
ле  че  ња.
Ме  то  де ра  да Ис  тра  жи  ва  њем су об  у  хва  ће  на 222 бо  ле  сни  ка 
(132 му  шкар  ца и 90 же  на, ста  ро  сти од 57,3±11,9 го  ди  на) из 
три цен  тра за хе  мо  ди  ја  ли  зу у цен  трал  ној Ср  би  ји. Ква  ли  тет 
спа  ва  ња је про  це  њен Пит  сбур  шким ин  дек  сом ква  ли  те  та 
спа  ва  ња (PSQI), по  сто  ја  ње де  пре  си  је Бе  ко  вим ин  дек  сом де-
пре  си  је (BDI), а де  мо  граф  ски и по  да  ци о ла  бо  ра  то  риј  ским 
ана  ли  за  ма узе  ти су из исто  ри  ја бо  ле  сти.
Ре  зул  та  ти Про  сеч  на вред  ност BDI би  ла је 16,1±11,3. Бо  ле-
сни  ци са де  пре  си  јом су би  ли ста  ти  стич  ки зна  чај  но ста  ри  ји 
(p=0,041), има  ли ло  ши  ју аде  кват  ност ди  ја  ли  зе (p=0,027) и 
ло  ши  ји ква  ли  тет спа  ва  ња (p<0.001), али ни  су се зна  чај  но 
раз  ли  ко  ва  ли по по  лу, рад  ном и брач  ном ста  ту  су, по  сто  ја-
њу ко  мор  би  ди  те  та, вр  сти, сме  ни и тра  ја  њу ди  ја  ли  зе, нити 
вред  но  сти  ма ла  бо  ра  то  риј  ских па  ра  ме  та  ра у од  но  су на бо-
ле  сни  ке без зна  ко  ва де  пре  си  је. Про  сеч  на вред  ност PSQI 
би  ла је 7,8±4,5, а 64,2% бо  ле  сни  ка су има  ла лош ква  ли  тет 
спа  ва  ња. Бо  ле  сни  ци с ло  шим ква  ли  те  том спа  ва  ња су ста  ти-
стич  ки зна  чај  но че  шће би  ли жен  ског по  ла (p=0,027), ста  ри  ји 
(p=0,002) и са ви  шим вред  но  сти  ма BDI (p<0,001). До  ка  за  на 
је ста  ти  стич  ки зна  чај  на по  зи  тив  на ко  ре  ла  ци  ја из  ме  ђу BDI и 
PSQI (r=0,604; p<0,001).
За  кљу  чак Де  пре  си  ја и лош ква  ли  тет спа  ва  ња су че  сти и ме-
ђу  соб  но по  ве  за  ни код бо  ле  сни  ка на хе  мо  ди  ја  ли  зи.
Кључ  не ре  чи: де  пре  си  ја; ква  ли  тет спа  ва  ња; ди  ја  ли  за; хе-
мо  ди  ја  ли  за
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